Ember LifeSciences Secures $16.5M for Temperature-Controlled Pharma Delivery
Update: 2025-12-17
Description
Ember LifeSciences, a healthcare logistics tech company, raised $16.5M in Series A funding to expand their specialized shipping containers for pharmaceuticals. Their goal is to improve temperature control and provide real-time tracking, addressing a $35B annual issue in the industry. The funding, led by Sea Court Capital, will support their second-generation container, Ember Cube Two, designed for high-volume patient deliveries. Ember LifeSciences aims to make continuous temperature tracking a standard requirement for high-value drugs.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
